Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Oncol.

Sec. Radiation Oncology

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1607218

This article is part of the Research TopicAI-Based Prognosis Prediction and Dose Optimization Strategy in Radiotherapy for Malignant TumorsView all 6 articles

Deep learning-based multi-omics model to predict nasopharyngeal necrosis of reirradiation for recurrent nasopharyngeal carcinoma

Provisionally accepted
Xingwang  GaoXingwang Gao1Yinglin  PengYinglin Peng1Shanfu  LuShanfu Lu2Yuhan  AnYuhan An1Meining  ChenMeining Chen1Jun  ZhangJun Zhang1Runda  HuangRunda Huang1Jingjing  MiaoJingjing Miao1Yiran  WangYiran Wang2Zhenyu  QiZhenyu Qi1Yao  LuYao Lu3Chong  ZhaoChong Zhao1Xiaowu  DengXiaowu Deng1Yimei  LiuYimei Liu1*
  • 1Sun Yat-sen University Cancer Center (SYSUCC), Guangzhou, China
  • 2Perception Vision Medical Technologies Co. Ltd, Guangzhou, China
  • 3School of Data and Computer Science, Sun Yat-sen University, Guangzhou, China

The final, formatted version of the article will be published soon.

Background and Purpose: Patients with recurrent nasopharyngeal carcinoma (rNPC) undergoing reirradiation have a high risk of lethal nasopharyngeal necrosis (NN), which may lead to massive nasopharyngeal hemorrhage or death. Predicting NN is crucial to improve the prognosis of these patients.We aimed to utilize deep learning techniques in combination with multi-sequence magnetic resonance imaging (MRI) radiomics and dosiomics to predict the risk of nasopharyngeal necrosis in patients with recurrent nasopharyngeal carcinoma undergoing re-irradiation therapy.: 117 patients with rNPC were included, comprising pre-treatment multisequence MR images (including T1, T1C, and T2 sequences) and a planned re-irradiation therapy dose distribution. A three-dimensional (3D) convolutional neural network (CNN) deep learning network model was utilized to integrate the selected MRI radiomics and dosiomics features. Eight prediction deep learning models were developed for training, 97 cases were used as the training set and 20 as the test set. The performance and prediction accuracy of each deep learning network model were then evaluated. Results: Thirty-two features correlated with necrosis of rNPC. The model based on multi-sequence MRI radiomics could better predict necrosis. The models combining radiomics and dosiomics features were more accurate for the prediction of NN, especially the model of multi-sequence MRI radiomics plus dosiomics, which showed the best performance in the test set, with an AUC, ACC, and F1-Score of 0.81, 0.75, and 0.74, respectively.The deep learning model leveraging pre-treatment multi-sequence MRI radiomics and dosiomics of re-irradiation therapy can serve as a potential predictor of NN in patients with recurrent nasopharyngeal carcinoma, thereby improving clinical decision-making processes.

Keywords: AI, artificial intelligence, CNN, convolutional neural network, FN, false negative, FP, false positive, rGTV, recurrent Gross tumor volume, MRI, magnetic resonance imaging, NN, Nasopharyngeal necrosis, ROC, receiver operating characteristic

Received: 07 Apr 2025; Accepted: 27 Jun 2025.

Copyright: © 2025 Gao, Peng, Lu, An, Chen, Zhang, Huang, Miao, Wang, Qi, Lu, Zhao, Deng and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Yimei Liu, Sun Yat-sen University Cancer Center (SYSUCC), Guangzhou, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.